Nautilus Biotechnology to Announce First Quarter 2026 Financial Results on April 28, 2026
Nautilus Biotechnology (NASDAQ: NAUT) will report first quarter 2026 financial results before market open on April 28, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Nautilus Biotechnology (NASDAQ: NAUT) will report first quarter 2026 financial results before market open on April 28, 2026. Management will host a webcast and conference call at 5:30 a.m. PT / 8:30 a.m. ET to discuss results, business developments, and outlook. Live audio will be available on the company Investors website.
Details
News Market Reaction – NAUT
On Apr 9, the day this news came out, NAUT closed 2.88% below the previous close.
Data tracked by StockTitan Argus for the Apr 9 session.
Key Figures
- Earnings date
- April 28, 2026
- Q1 2026 financial results report date
- Webcast time PT
- 5:30 a.m. Pacific Time
- Conference call start time
- Webcast time ET
- 8:30 a.m. Eastern Time
- Conference call start time
Previous Earnings date Reports
-
Scheduled Q4 and FY2025 results with webcast details before market open.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Key Terms
single-molecule protein analysis platform technical
AI-generated analysis. How Rhea-AI works. Not financial advice.
SEATTLE, April 09, 2026 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform, today announced it will report financial results for the first quarter 2026 before market open on Tuesday, April 28, 2026.
The company’s management will webcast a corresponding conference call beginning at 5:30 a.m. Pacific Time / 8:30 a.m. Eastern Time to discuss its results, business developments, and outlook. Live audio of the webcast will be available on the “Investors” section of the company website at: www.nautilus.bio.
About Nautilus Biotechnology, Inc.
With its corporate headquarters in Seattle, Washington and its research and development headquarters in San Carlos, California, Nautilus is a development stage life sciences company working to create a platform technology for quantifying and unlocking the complexity of the proteome. Nautilus’ mission is to transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. To learn more about Nautilus, visit www.nautilus.bio.
Media Contact
press@nautilus.bio
Investor Contact
investorrelations@nautilus.bio
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.